CNN’s Elizabeth Cohen reports on the controversy behind the first Alzheimer’s disease treatment approved by the US Food and Drug Administration in 20 years.
Why the newest Alzheimer's drug is controversial
- More about:
Elizabeth Cohen- Food and Drug Administration
